Search
Date and Time
Tuesday, February 20, 2018
6:00 PM – 8:30 PM

Sheraton Seattle Hotel
1400 Sixth Avenue
Seattle, WA 98101
Click Here for directions


Activity Co-Chairs
David Aboulafia, MD (pictured top)
Virgina Mason Medical Center


Hank Kaplan, MD (pictured bottom)
Swedish Medical Center 


Register online here

David Aboulafia, MD Hank Kaplan, MD

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, pharmon@lymphoma.org. Exhibit opportunities are also available, however, space is limited.


Program Agenda –

6:00 PMRegistration and Dinner Buffet

6:45 PMWelcome Max Mulcahy, MPA, Lymphoma Research Foundation
John Pagel, MD, PhD, DSc, Swedish Medical Center

Pathology for all cases will be presented by Sony Kilgore, MD, Kaiser Permanente

7:00 PM A Case of EBV DLBCL in the Backdrop of Chronic Antigenic Stimulation
Peter Whooley, MD, Virginia Mason Medical Center

Moderator

David Aboulafia, MD, Virginia Mason Medical Center

7:30 PM Aggressive T-cell Lymphoma Alexandra Sokolova, MD, University of Washington / Fred Hutchinson Cancer Research Center
Moderator

Hank Kaplan, MD, Swedish Medical Center

8:00 PM A Case of Peripheral T-Cell Lymphoma
Albert Yeh, MD, University of Washington / Fred Hutchinson Cancer Research Center
Moderator

Nina Lamble, MD, Seattle Cancer Care Alliance at UW Medicine's Northwest Hospital

8:30 PM Adjourn


Register Online Here


2017–18 Seattle Lymphoma Rounds Series –

Wednesday, November 8, 2017
Tuesday, February 20, 2018
Wednesday, April 25, 2018


About the Program
The Lymphoma Research Foundation's Seattle Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Seattle area.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.

Additional Information
This program is free for healthcare professionals; however, pre- registration is required. Food and refreshments will be provided for all registered participants.

Seattle Lymphoma Rounds Steering Committee

Kaiser Permanente Washington
Eric Chen, MD, PhD
The Polyclinic
Sherry Hu, MD, PhD
Swedish Medical Center
Hank Kaplan, MD
John Pagel, MD, PhD, DSc (chair)
University of Washington
Paul S. Martin, MD
University of Washington/Fred Hutchinson Cancer Research Center
Ryan Cassaday, MD
Virginia Mason Medical Center
David Aboulafia, MD


Sponsors






This activity is supported by educational grants from:

AbbVie, Celgene, Genentech, Juno Therapeutics, Kite Pharma, Pharmacyclics LLC and Janssen Biotech, Inc., Seattle Genetics, Spectrum Pharmaceuticals, Teva Pharmaceuticals Industries, LTD and TG Therapeutics

Joint Providership Statement

This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.